Rahul S. Vedula, MD

Dr. Vedula is translational-clinical investigator and physician in the Adult Leukemia Program at Dana-Farber Cancer Institute. He received his MD from Tufts University School of Medicine. He completed his residency in internal medicine at Brigham and Women's Hospital and his fellowship in hematology/oncology at Dana-Farber/Mass General Brigham. He joined the Division of Leukemia in 2020 where he focuses on the care of patients with myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and myeloproliferative neoplasms (MPNs).  His research focuses on understanding the impact of genetic mutations on myeloid disease progression, therapy response in early phase clinical trials, measurable residual disease, and patient outcomes.